ECMO Hemostatic Transfusions in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

January 2, 2025

Study Completion Date

March 25, 2025

Conditions
Extracorporeal Membrane Oxygenation ComplicationHemorrhageThromboembolismTransfusion Adverse Reaction
Interventions
BIOLOGICAL

Platelet Transfusion

Participants will be transfused according to the assigned threshold for each group, with a transfusion dose of 10 mL/kg, up to one adult unit.

Trial Locations (10)

10032

Morgan Stanley Children's Hospital of New York Presbyterian, New York

10065

Komansky Children's Hospital of New York Presbyterian, New York

14642

Golisano Children's Hospital, Rochester

23219

Children's Hospital of Richmond at VCU, Richmond

27710

Duke University School of Medicine, Durham

30322

Children's Healthcare of Atlanta - Emory, Atlanta

40202

Norton Children's Hospital, Louisville

49504

Schneider Children's Medical Center, Petah Tikva

52242

University of Iowa Health Care, Iowa City

53226

Children's Hospital of Wisconsin, Milwaukee

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

University of Utah

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Columbia University

OTHER

collaborator

Virginia Commonwealth University

OTHER

collaborator

University of Rochester

OTHER

collaborator

Children's Hospital and Health System Foundation, Wisconsin

OTHER

collaborator

Duke University

OTHER

collaborator

Johns Hopkins All Children's Hospital

OTHER

collaborator

University of Iowa

OTHER

collaborator

Emory University

OTHER

collaborator

Schneider Medical Children's Center, Israel

UNKNOWN

lead

Yale University

OTHER

NCT05796557 - ECMO Hemostatic Transfusions in Children | Biotech Hunter | Biotech Hunter